ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

This is my first cover of ADMA Biologics (NASDAQ: ADMA ). In the article, I will describe ADMA Biologics' business areas and my opinion on how they will affect the company's future. I will try to compare ADMA's product to the competition andI first entered investing in 2016 as an individual value investor. In 2022, I established the investment firm Libra Capital. I mostly write articles as part of my deep research into a company before I make an investment, whether long or short. For me, a ''hold'' article ...